Broker: Credit Suisse
Target price: Rs 720
CMP: Rs 593.3
Potential increase: 21.3%
The agency reduced the stock’s target price to Rs 720 from Rs 790, while maintaining a better performance Rating. The brokerage has cut its earnings-per-share estimate from fiscal year 23 to fiscal 25 by 4-9% due to concerns about lower operating margins and slower growth in operations. trade in common injectable drugs. Credit Suisse said the company’s global generic injection sales guidance would be difficult to achieve.
Broker: CLSA
Target Price: Rs 850
CMP: Rs 688.6
Potential increase: 23.4%
CLSA raised its target price of the stock to Rs 850 from Rs 805 and maintained its buy rating. The brokerage said it is bullish on the property developer as it focuses on the Bangalore property market, where housing demand outlook remains strong. CLSA said Sobha generated free cash flow for the seventh consecutive quarter from April to June, which led to its debt levels falling.
Broker: Bank of America
Target Price: Rs 945
CMP: Rs 682.1
Potential increase: 38.6%
Bank of America said the stock could be revalued if the insurance giant continues to achieve growth and profit margins. The brokerage said that LIC is trading at a strong 70% discount on a Price-to-Enterprise Value basis compared to its domestic listed peers. It said LIC remains focused on strengthening its non-corporate business, which will help it balance the product basket and improve overall margins.
Broker: Morgan Stanley
Target Price: Rs 3,015
CMP: Rs 2,632.6
Potential increase: 14.6%
Morgan Stanley says Reliance’s annual report for fiscal year 22 focuses on the energy transition and sustainability. “Investors always look at balance sheet health deeply, but RIL’s new energy plans also stand out this year in its annual report,” the broker said, adding assign an overvalued rating to the stock.
Zee Entertainment
Broker: Ambit Capital
Target Price: Rs 340
CMP: Rs 241.8
Potential increase: 40.5%
“We expect the company to leverage its market leadership position with increased investment based on Sony’s global OTT content expertise and the dominant presence of panIndia TVs,” said Ambit. ZEEL”. The brokerage says Zee’s valuation based on a Price-to-Earnings (PE) ratio is ‘no claim’, 12 times its estimated earnings for fiscal 24. Zee can yield a RoE ratio of twelfth%.
